Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 14 February

Jessica Amir
February 14, 2020

Morning Bell 11 February

Jessica Amir
February 11, 2020

Morning Bell 10 February

Jessica Amir
February 10, 2020

Morning Bell 7 February

Jessica Amir
February 7, 2020

Reporting season: Mirvac results

Jessica Amir
February 6, 2020

Morning Bell 6 February

Jessica Amir
February 6, 2020

Morning Bell 5 February

Jessica Amir
February 5, 2020

Morning Bell 4 February

Jessica Amir
February 4, 2020